Skip to main content

TNMG · TNL Mediagene

Track TNMG — free
$3.20 +0.20 (+6.67%)
Market Cap
$2.22M
Shares
760,573
Volume · Oct 21 341.07K Avg daily vol (31 sessions) 1.86M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.00 Open$2.84 Day$2.83–3.20 52W close$0.34–8.22 Avg vol 30d1.9M Short int25K · 3.3% float · 1.0d Short vol32% DataDec 2024–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-7.2%
Year over year
Operating margin
-110.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+95.7%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
3.3%
Latest settlement · 1.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +16%
above
Price vs 50-day avg +17%
above
RSI (14) 44
neutral
MACD trend Negative
52-week position 34%
mid-range
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Strong
1-month return −23%
trailing
6-month return +13%
trailing
YTD return +10%
this year
Relative strength +5%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow Accumulating
+150% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.33% of float · ▲ +257.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — mid 1-yr range
Squeeze score 54
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 1105%
annualized · 1-yr
Max drawdown −97%
past year
ATR 15.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+16% Bullish
Price vs 50-day avg
+17% Bullish
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
34% Neutral
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow Accumulating
+150% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.33% of float · ▲ +257.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $0 Now $3 · 34% Range high $8
vs 200-day avg +16% vs 50-day avg +17%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Publishing — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TNMG
TNL Mediagene
this stock
$2.22M — — — 3.3%
NYT
New York Times Co
$11.22B +0.2% -1.6% 29.0 11.4%
PSO
Pearson PLC
$10.96B +29.9% — — 0.7%
WLY
John Wiley & Sons, Inc.
$2.67B +70.7% +4.5% 14.2 8.8%
SPGNY
Springer Nature AG & Co. KGaA/ADR
$2.51B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
5
% held
1.0%
Net QoQ
+2.2K sh
Top holder
SUSQUEHANNA INTERNATIONAL…
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
25.3K
Days to cover
1.0d
Change
+18.2K sh
View
Short Volume
Short vol %
32%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
343
Value
$1.5K
As of
Sep 29, 2026
View
Off-Exchange
Off-exchange %
50.3%
Week of
Sep 14, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 16, 2026
This year
14

TNL Mediagene received a Nasdaq letter on October 14, 2026 confirming it regained compliance with the minimum bid price requirement, but remains non-compliant with the stockholders' equity requirement and must demonstrate compliance on or before October 30, 2026.

View

Performance

5D 20D 120D MTD YTD
TNMG -11.2% -23.3% +12.8% -25.9% +9.9%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -10.1% -22.7% +4.7% -26.8% -2.9%
Key facts CIK 2013186 CUSIP G8924F139 Visit website Investor relations